Serina Therapeutics Inc (SER) stock news · rev $130.0K
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
This SER news page leads with what Serina Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for SER yet. We will not pad this page with generic market recap.
Latest reported SER revenue for 2025-12-31 was $130.0K. Net income was -$19.2M. Revenue was down 8.5% from 2023-12-31 to 2025-12-31. SER currently screens at market cap $29.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SER stock page; for the tape open the quote page.
SER stock news FAQ
What are SER's latest revenue and net income?
Latest cached Serina Therapeutics Inc (SER) revenue for Dec 31, 2025 was $130.0K. Net income was -$19.2M. Statements: https://lician.com/financials/ser
How did SER revenue change from the prior cached period?
Cached Serina Therapeutics Inc (SER) revenue was down 8.5% from $142.0K (Dec 31, 2023) to $130.0K (Dec 31, 2025). Statements: https://lician.com/financials/ser
What is SER's market cap?
Serina Therapeutics Inc (SER) market cap is $29.7M on the latest cached fundamentals snapshot.
What kind of company is SER?
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Where is SER stock news listed?
Cached stock news for Serina Therapeutics Inc (SER) is listed at https://lician.com/news/ser. Filings: https://lician.com/sec/ser
Not investment advice.